Carolyn Wrightson

Dr. Wrightson is a proven Chief Operating/Technical Officer with over 25 years’ successful leadership experience in scientific and technical operations, and research and development in the regenerative medicine, protein expression and genomic diagnostics industries for both human and veterinary markets. Excellent track record in partnering with top management and driving strategic value creation. Known for streamlining operations through reengineering and building highly skilled and motivated teams to deliver strong business results. Responsible for meeting growth requirements as well as assisting with strategic, regulatory, clinical, and scientific functions. Well versed in agency interactions from writing product characterization, manufacturing and controls technical section submissions as well as leading technical aspects of pre-approval and licensure audit inspections. Fiscally responsible mindset to develop corporate value in early-stage development process, build and communicate business acumen, foster collaboration and teamwork among staff through engagement and coaching to develop teams that deliver results. Known for working hand in hand with Quality staff to deliver safe and effective cell therapy products. Carolyn’s prior roles include COO/CTO of Performance Cell Manufacturing (Cellipont Bioservices, a cell therapy CDMO), as well as COO of VetStem Biopharma where she led laboratory operations and manufacturing development for 15 years, and as Group Leader at Sequenom for 7 years. Carolyn has received a dual B.S. in Biology and Biochemistry from Mount St. Mary’s University, earned her Ph.D. in Pathobiology from the University of Southern California, and completed her post-doctoral fellowship at The Scripps Research Institute department of Molecular and Experimental Medicine.